Alamar Biosciences
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
47071 Bayside Pkwy, Fremont, California,...Phone Number
(510) 626-9888Website
www.alamarbio.comRevenue
$100.4 MillionStock Symbol
ALMRIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
2
2
2
2
About Alamar Biosciences
Alamar Biosciences is a privately held life-science technology company focused on powering precision proteomics to enable the earliest detection of disease. It develops ultra-sensitive protein analysis platforms and assays that help researchers profile biomarkers from blood samples with unprecedented breadth and depth, advancing biomarker discovery, drug research and translational science.Explore more
Alamar Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alamar Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Alamar Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once Alamar Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Alamar Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Alamar Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Alamar Biosciences
Check out if Alamar Biosciences is spiking on competitors!
Click to see if Alamar Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Alamar Biosciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Alamar Biosciences
Compare insights from companies similar to Alamar Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alamar Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Alamar Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Alamar Biosciences.
Alamar Biosciences financials insights
Gather financial insights about Alamar Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$14M
2021
Series B
$80M
2024
Series C
$100M
2025
Other Financing Round
$10M
Alamar Biosciences Tech Stack
A closer look at the technologies used by Alamar Biosciences
Most Recent Scoops
Project
Alamar Biosciences is developing a clinical instrument, ARGO HT DX, as part of a phased diagnostic enablement strategy that includes seeking FDA marketing authorization to establish the platform's suitability for clinical use, followed by partnering with IVD and LDT companies to support the development of differentiated diagnostic tests.
Clinical Operations
Earnings
Alamar Biosciences has reported a net loss of $13.2 million for Q2 2026, compared to a net loss of $7 million in Q2 2025, including $3.3 million of stock-based compensation.
Earnings, Finance
Earnings
Alamar Biosciences has reported service and other revenue of $6.2 million for Q2 2026, up 49% year over year, driven primarily by larger custom assay development projects within the company's technology access program.
Earnings, Finance
Earnings
Alamar Biosciences has reported instrument revenue of $7.8 million for Q2 2026, up 35% year over year, driven by continued growth in new instrument placements.
Earnings, Finance
Earnings
Earnings, Accounting, Financial Reporting, Finance
Alamar Biosciences News & Media
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
FREMONT, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended June 30, 2026.Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
Expanded collaboration applies multiplex protein profiling across 86,000 additional samples, enabling researchers to move beyond single biomarkers toward a precision-medicine understanding of disease heterogeneity, subtypes, and trajectoriesAlamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive multiplex measurement captures regulatory proteins, like checkpoint inhibitors, and low abundance targets that standard platforms routinely miss Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, auAlamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alamar Biosciences
Sign Up For FreeTo access detailed company insights
Alamar Biosciences is a privately held life-science technology company focused on powering precision proteomics to enable the earliest detection of disease. It develops ultra-sensitive protein analysis platforms and assays that help researchers profile biomarkers from blood samples with unprecedented breadth and depth, advancing biomarker discovery... Read More
